FDA Enforcement Class II Ongoing

CareLink SmartSync Device Manager - Product Usage: used to treat arrhythmias related to bradycardia. Additionally, CRT-P devices can also provide cardiac resynchronization therapy (CRT) in treatment of heart failure, Model Number 24970A

Recall: Z-1528-2021 · Reported May 12, 2021

Enforcement

Recall Number
Z-1528-2021
Event ID
87662
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
May 12, 2021
Initiation Date
April 6, 2021
Classification Date
May 4, 2021
Address
8200 Coral Sea St Ne, N/A, Mounds View, MN, 55112-4391, United States

Description

CareLink SmartSync Device Manager - Product Usage: used to treat arrhythmias related to bradycardia. Additionally, CRT-P devices can also provide cardiac resynchronization therapy (CRT) in treatment of heart failure, Model Number 24970A

Reason

A longevity estimation error may occur in the early years of device life when a unipolar pacing vector is programmed in the right atrial (RA) lead and/or the right ventricular (RV) lead. No other device features or therapies are impacted.

Code Info

all codes

Distribution

Worldwide distribution.

Quantity

16,311 units